logo image
search icon
Global Coronavirus Vaccine Market

Coronavirus Vaccine Market Size, Share & Trends Analysis Report By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, and MERS-CoV), Vaccine Type (Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, S-Protein based coronavirus vaccine), Region, And Segment Forecasts, 2023-2031.

Report ID : 1019 | Published : 2023-06-16 | Pages: 185 | Format:

The Coronavirus Vaccine Market is expected to grow at a -25.0 % CAGR during the forecast period for 2023-2031.

Coronavirus Vaccine Market

Coronavirus Disease (COVID-19) is caused by coronavirus. Coronavirus is a type of virus which causes respiratory illness in humans and can causes serious illness in geriatric population (Mainly those with diabetes, chronic respiratory disease, cardiovascular disease, and cancer). Out of the seven types of coronavirus, SARS-CoV-2 is the one which can cause severe diseases like Middle East respiratory syndrome (MERS) and sudden acute respiratory syndrome (SARS).  Increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines, which will result in expansion of coronavirus vaccine market during the forecast period.

Major factors responsible for the growth of this market are fast adoption of advance technologies, growing number of corona patients, increasing healthcare expenditures, rising awareness about corona virus, and increasing efforts by the pharmaceutical companies for the development of covid-19  vaccines. Furthermore, increasing research investments for the R&D of covid-19 vaccines is anticipated to drive the market growth in future. However, high cost required for clinical trials and for validation of vaccines is restraining the growth of coronavirus vaccine market.

Market Segmentation

The Coronavirus Vaccine Market can be segmented on the basis of Infection Type, Vaccine Type, End-Users, and region. On the basis of Infection Type, the market can be divided into HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, and MERS-CoV. SARS-CoV segment is expected to dominate the market as this virus is the main reason of covid-19 outbreak. On the basis of Vaccine Type, the market can be segmented into Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, and S-Protein based coronavirus vaccine. In terms of End-Users, market is divided into Hospitals, Clinics, Research Institutes, and Others. On the basis of region, the market is segmented into the North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the coronavirus vaccine market in the coming future.

Competitive Landscape

Some of The Key Players in The Coronavirus Vaccine Market:

  • I-Mab Biopharma
  • Medicago
  • Airway Therapeutics
  • Tiziana Life Sciences
  • Inovio Pharmaceuticals
  • Novavax, Inc
  • Moderna
  • AstraZeneca
  • Pfizer
  • Johnson &Johnson
  • GlaxoSmithKline
  • Bharath Biotech
  • Serum Institute of India
  • Sinopharm
  • AnGes
  • AIVITABiomedical
  • CanSinoBio
  • eubiologics
  • Genexine
  • GreenLight Bioscience
  • Gennova
  • Heat Biologics
  • INOVIO
  • IIBR
  • medicago
  • Symvivo
  • Valneva
  • Zydus Cadila
  • CODAGENIX Inc.
  • Other Prominent Players

The Coronavirus Vaccine Market Report Scope

Report Attribute

Specifications

Growth Rate CAGR

CAGR of -25.0 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Infection Type, By Vaccine Type, By End-Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

I-Mab Biopharma, Medicago, Airway Therapeutics, Tiziana Life Sciences, Inovio Pharmaceuticals, Novavax, Inc, Moderna, AstraZeneca, Pfizer, Johnson &Johnson, GlaxoSmithKline, Bharath Biotech, Serum Institute of India, Sinopharm, AnGes, AIVITABiomedical, CanSinoBio, eubiologics, Genexine, GreenLight Bioscience, Gennova, Heat Biologics, INOVIO, IIBR, medicago, Symvivo, Valneva, Zydus Cadila, and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Coronavirus Vaccine Market Snapshot

Chapter 4. Global Coronavirus Vaccine Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Clinical Trial/Pipeline Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Major Investment, Partnerships and Collaborations in COVID 19 Research

Chapter 5. Market Segmentation 1: By Infection Type, Estimates & Trend Analysis

5.1. By Infection Type, & Market Share, 2020 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Infection Type:

5.2.1. HCoV-229E

5.2.2. HCoV-OC43

5.2.3. SARS-CoV

5.2.4. New Haven CoV

5.2.5. HKU1-CoV

5.2.6. MERS-CoV

Chapter 6. Market Segmentation 2: By Vaccine Type Estimates & Trend Analysis

6.1. By Vaccine Type & Market Share, 2020 & 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By Vaccine Type:

6.2.1. Protein subunit

6.2.2. Viral Vector (non-replicating)

6.2.3. DNA

6.2.4. Inactivated Virus

6.2.5. RNA

6.2.6. Viral Vector (replicating)

6.2.7. Virus Like Particle

6.2.8. Others

Chapter 7. Market Segmentation 3: By End-Users Estimates & Trend Analysis

7.1. By End-Users & Market Share, 2020& 2030

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 for the following By End-Users:

7.2.1. Hospitals

7.2.2. Clinics

7.2.3. Research Institutes

7.2.4. Others

Chapter 8. Coronavirus Vaccine Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By Infection Type, 2020-2030

8.1.2. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By Vaccine Type, 2020-2030

8.1.3. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts By End-Users, 2020-2030

8.1.4. North America Coronavirus Vaccine Market revenue (US$ Million) estimates and forecasts by country, 2020-2030

8.2. Europe

8.2.1. Europe Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, 2020-2030

8.2.2. Europe Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, 2020-2030

8.2.3. Europe Coronavirus Vaccine Market revenue (US$ Million) By End-Users, 2020-2030

8.2.4. Europe Coronavirus Vaccine Market revenue (US$ Million) by country, 2020-2030

8.3. Asia Pacific

8.3.1. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, 2020-2030

8.3.2. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, 2020-2030

8.3.3. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) By End-Users, 2020-2030

8.3.4. Asia Pacific Coronavirus Vaccine Market revenue (US$ Million) by country, 2020-2030

8.4. Latin America

8.4.1. Latin America Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, (US$ Million)

8.4.2. Latin America Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, (US$ Million)

8.4.3. Latin America Coronavirus Vaccine Market revenue (US$ Million) By End-Users, (US$ Million)

8.4.4. Latin America Coronavirus Vaccine Market revenue (US$ Million) by country, (US$ Million) 2020-2030

8.5. Middle East & Africa

8.5.1. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By Infection Type, (US$ Million)

8.5.2. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By Vaccine Type, (US$ Million)

8.5.3. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) By End-Users, (US$ Million)

8.5.4. Middle East & Africa Coronavirus Vaccine Market revenue (US$ Million) by country, (US$ Million) 2020-2030

Chapter 9. Competitive Landscape

9.1. Company Profiles

9.1.1. I-Mab Biopharma

9.1.2. Medicago

9.1.3. Airway Therapeutics

9.1.4. Tiziana Life Sciences

9.1.5. Inovio Pharmaceuticals

9.1.6.  Novavax, Inc

9.1.7. Moderna

9.1.8. AstraZeneca

9.1.9. Pfizer

9.1.10. Johnson &Johnson

9.1.11. GlaxoSmithKline

9.1.12. Bharath Biotech

9.1.13. Serum Institute of India

9.1.14. Sinopharm

9.1.15. AnGes

9.1.16. AIVITABiomedical

9.1.17. CanSinoBio

9.1.18. eubiologics

9.1.19. Genexine

9.1.20. GreenLight Bioscience

9.1.21. Gennova

9.1.22. Heat Biologics

9.1.23. INOVIO

9.1.24. IIBR

9.1.25. medicago

9.1.26. Symvivo

9.1.27. Valneva

9.1.28. Zydus Cadila

9.1.29. CODAGENIX Inc.

9.1.30. Other Prominent Player

Market Segmentation of Coronavirus Vaccine Market

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Infection Type

  • HCoV-229E
  • HCoV-OC43
  • SARS-CoV
  • New Haven CoV
  • HKU1-CoV
  • MERS-CoV

Coronavirus Vaccine Market

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Vaccine Type

  • Inactivated coronavirus vaccine
  • Live attenuated coronavirus vaccine
  • S-Protein based coronavirus vaccine

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on End-Users

  • Hospitals
  • Clinics
  • Research Institutes
  • Others

Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2030 based on Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030

  • U.S.
  • Canada

Europe coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030

  • Brazil
  • Mexico
  • Rest of Latin America

 Middle East & Africa coronavirus vaccine market revenue (US$ Million) by Country, 2020 to 2030

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Landscape

  • Company Overview
  • Financial Performance
  • Key Development
  • Latest Strategic Developments

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

Who are the Key Players in the Global Coronavirus Vaccine Market ?

The Coronavirus Vaccine Market is expected to grow at a -25.0 % CAGR during the forecast period for 2023-2031.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4268
$7682
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach